Natriumthiosulfat 25%

DRUG2 trials

Sponsors

Universitair Medisch Centrum Groningen, Radboud universitair medisch centrum Stichting

Conditions

Raynaud’s phenomenonVascular Calcification

Phase 2

STS-001: An explorative clinical study to assess the potential of intravenously administered sodium thiosulfate in subjects with primary Raynaud’s phenomenon

RecruitingCTIS2023-509432-25-00

Universitair Medisch Centrum GroningenRaynaud’s phenomenon

Start: 2025-10-24Target: 12Updated: 2025-12-19

Attenuating Calciprotein particles Transformation and Inhibiting Vascular calcification Evolution by Sodium ThioSulphate trial

Not yet recruitingCTIS2026-525680-41-00

Radboud universitair medisch centrum StichtingVascular Calcification

Target: 40Updated: 2026-09-11